Firebrick Pharma Ltd (FRE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.543x

Based on the latest financial reports, Firebrick Pharma Ltd (FRE) has a cash flow conversion efficiency ratio of -0.543x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.05 Million ≈ $-745.48K USD) by net assets (AU$1.94 Million ≈ $1.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Firebrick Pharma Ltd (FRE) market capitalisation for the company's overall valuation and market capitalisation.

Firebrick Pharma Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Firebrick Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Firebrick Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Firebrick Pharma Ltd ranked by their cash flow conversion efficiency. See FRE operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Straker Ltd AU:STG	-0.422x
Alfa Financial Software Holdings PLC LSE:ALFA	0.350x
iMetal Resources Inc V:IMR	-0.024x
Trifecta Gold Ltd V:TG	-0.014x
Goodbye Kansas Group AB (publ) ST:GBK	0.025x
E Investment & Development KO:093230	-0.020x
Sego Resources Inc V:SGZ	-0.015x
Cardio Diagnostics Holdings Inc NASDAQ:CDIO	-0.181x

Annual Cash Flow Conversion Efficiency for Firebrick Pharma Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of Firebrick Pharma Ltd from 2019 to 2025. View today's stock price for Firebrick Pharma Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.56 Million ≈ $1.10 Million	AU$-1.78 Million ≈ $-1.26 Million	-1.143x	-3.12%
2024-06-30	AU$2.12 Million ≈ $1.50 Million	AU$-2.34 Million ≈ $-1.66 Million	-1.109x	+52.54%
2023-06-30	AU$2.48 Million ≈ $1.75 Million	AU$-5.78 Million ≈ $-4.09 Million	-2.336x	-360.20%
2022-06-30	AU$8.28 Million ≈ $5.86 Million	AU$-4.20 Million ≈ $-2.97 Million	-0.508x	-202.88%
2021-06-30	AU$11.55 Million ≈ $8.17 Million	AU$-1.94 Million ≈ $-1.37 Million	-0.168x	+93.35%
2020-06-30	AU$390.60K ≈ $276.37K	AU$-985.01K ≈ $-696.96K	-2.522x	-155.58%
2019-06-30	AU$1.08 Million ≈ $763.34K	AU$-1.06 Million ≈ $-753.18K	-0.987x	--

About Firebrick Pharma Ltd

AU:FRE Australia Drug Manufacturers - General

Market Cap

$5.69 Million

AU$8.04 Million AUD

Market Cap Rank

#28450 Global

#1498 in Australia

Share Price

AU$0.03

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.07

All Time High

AU$0.65